Form 4: Rallybio Corp Director, Paula Soteropoulos, Acquires Options

Paula Soteropoulos, a director at Rallybio Corp, reports the acquisition of options to purchase 28,500 shares of common stock.

Summary

• On May 13, 2025, Paula Soteropoulos, a director of Rallybio Corp, acquired options to purchase 28,500 shares of the company's common stock.
• The options were granted under the company's 2021 Equity Incentive Plan.
• The exercise price of the options is $0.3.
• The options vest on the earlier of May 13, 2026, or the date of the company's 2026 Annual Meeting of Stockholders.
• The options expire on May 13, 2035.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing indicating an option grant to a director, which can be seen as a positive but doesn't necessarily indicate a major shift in the company's prospects.

Positives

• The acquisition of options by a director could be seen as a positive sign, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment, as it indicates a director's belief in the company's future.

Key Dates

Keywords

Rallybio Corp, RLYB, Form 4, Insider Trading, Paula Soteropoulos, Options, Equity Incentive Plan, Director